Skip to Content

Vaccines, Volume 14, Issue 6

2026 June - 89 articles

Cover Story: Patients with inflammatory bowel disease (IBD) receiving biologic or targeted therapies are generally advised to avoid live attenuated vaccines (LAVs) because of concerns regarding vaccine-associated infection. However, evidence supporting these recommendations is limited, and real-world safety data remain scarce. We conducted a multicenter propensity score-matched cohort study using the TriNetX Research Network to evaluate outcomes among adults with IBD who received a live attenuated vaccine while receiving biologic or targeted therapy. Rates of hospitalization, emergency department visits, fever, rash, pneumonia, sepsis, and encephalitis were compared with matched controls who did not receive a live attenuated vaccine. Our findings provide important real-world evidence regarding the safety of LAVs in this population. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (89)

  • Review
  • Open Access
1,785 Views
18 Pages

22 June 2026

Introduction: Inequities in access to medicines persist for asylum seekers, refugees, and undocumented migrants in Europe. For vaccines, access gaps not only exist for these groups in childhood routine immunization, but also for life-course and catch...

(This article belongs to the Special Issue The Role of Vaccination on Public Health and Epidemiology)
  • Review
  • Open Access
870 Views
15 Pages

22 June 2026

Human respiratory syncytial virus (HRSV) is a major cause of severe lower respiratory tract infections in infants, young children, and older adults worldwide. With the approval of nirsevimab and HRSV vaccines, accurate measurement of neutralizing ant...

(This article belongs to the Collection Research on Monoclonal Antibodies and Antibody Engineering)
  • Article
  • Open Access
1 Citations
730 Views
11 Pages

Insights from 25 Years of Measles and Measles–Rubella Vaccination Campaigns in the WHO African Region (2001–2025)

  • Balcha Girma Masresha,
  • Goitom Gebremedhin Weldegebriel,
  • Emmaculate Jepkorir Lebo,
  • Sarah Wanyoike,
  • Ado Mpia Bwaka and
  • Yolande Vuo-Masembe

22 June 2026

Introduction: The WHO African Region is working to eliminate measles and rubella in 80% of countries by 2030. In countries with sub-optimal routine immunization coverage, periodic supplemental Immunization Activities (SIAs) are implemented to boost c...

(This article belongs to the Section Vaccines and Public Health)
  • Article
  • Open Access
703 Views
13 Pages

Post-Marketing Safety Surveillance of Influenza Vaccines in Anhui Province, China, 2016–2025

  • Fanya Meng,
  • Sicheng Wei,
  • Binbing Wang,
  • Xianwei Luo and
  • Jiabing Wu

21 June 2026

Background: China’s influenza vaccine (InfV) has undergone multiple iterations and numerous technological breakthroughs, providing tremendous impetus and solid support for the development of China’s health sector. As the number of vaccina...

(This article belongs to the Special Issue Vaccines Against Influenza and Other Respiratory Virus Infections)
  • Article
  • Open Access
946 Views
10 Pages

20 June 2026

Background: Hypotonic–hyporesponsive episode (HHE) is a recognised adverse event following immunisation (AEFI) in infants, characterised by sudden hypotonia, hyporesponsiveness, and pallor or cyanosis. Although considered benign, its abrupt and...

(This article belongs to the Special Issue The Changing Epidemiology of Vaccine-Preventable Diseases)
  • Article
  • Open Access
941 Views
27 Pages

Faith, Science, and Choice: Vaccine Attitudes Among Religious University Students

  • Isaiah Aduse-Poku,
  • Keersty J. B. Thompson,
  • Afton Fillmore,
  • Leah Sim,
  • Isaac A. Woolley,
  • Elizabeth G. Bailey,
  • Brian D. Poole and
  • Jamie L. Jensen

20 June 2026

Background/Objectives: Vaccine attitudes are an individual’s beliefs, feelings, and evaluations regarding vaccines. Limited research has examined how students in faith-based university settings organize these attitudes. This study looked at vac...

(This article belongs to the Special Issue Acceptance and Hesitancy in Vaccine Uptake: 3rd Edition)
  • Article
  • Open Access
2 Citations
1,068 Views
19 Pages

Immunogenicity of a Recombinant Multi-Epitope Vaccine Incorporating GRA14, SAG1, and GRA1 Antigens of Toxoplasma gondii in BALB/c Mice

  • Abdulrahman M. Sheikh,
  • Wong Weng Kin,
  • Robaiza Zakaria,
  • Ahmad A. Alshehri,
  • Mohammed Dauda Goni,
  • Abdulrazzag Abdulaziz Othman,
  • Zakeya Al Rasbi,
  • Zeehaida Mohamed and
  • Khalid Hajissa

20 June 2026

Background: The high incidence and severe health threat of Toxoplasma gondii (T. gondii) infection, particularly in immunocompromised patients, underscore the urgent need for the development of a safe and effective vaccine. The aim of this study was...

(This article belongs to the Special Issue Host–Parasite Interactions and Vaccines)
  • Article
  • Open Access
834 Views
13 Pages

Incremental Effectiveness of a Second Varicella Vaccine in Children: A Prospective Cohort Study in Anhui, China

  • Kun Xuan,
  • Tao Li,
  • Zhenqiu Zha,
  • Shujie Zhou,
  • Feiyang Song,
  • Yu Chai,
  • Xianwei Luo,
  • Xingya Pang,
  • Qingru Li and
  • Jihai Tang
  • + 7 authors

20 June 2026

Background: Varicella remains a common vaccine-preventable disease in China. Although Anhui Province recommended a two-dose varicella vaccine (VarV) schedule in 2021, real-world evidence on the incremental benefit of the second dose is limited. Metho...

(This article belongs to the Special Issue Immunization, Data Analytics, and Surveillance for Vaccine-Preventable Diseases (VPDs))
  • Article
  • Open Access
884 Views
21 Pages

Magnetoencephalography Reveals Neuroprotection of COVID-19 Vaccination in Nonhuman Primates

  • Jennifer Stapleton-Kotloski,
  • Jared Rowland,
  • April Davenport,
  • Phillip Epperly,
  • Maria Blevins,
  • Dwayne Godwin,
  • Daniel Ewing,
  • Zhaodong Liang,
  • Appavu Sundaram and
  • James Daunais
  • + 3 authors

20 June 2026

Background/Objectives: COVID-19, caused by the SARS-CoV-2 virus, can lead to widespread neurological and cognitive complications, even in the absence of significant structural brain abnormalities. Understanding the evolving health concerns in the con...

(This article belongs to the Special Issue Neurobiological Impacts of Infection, Protective Effects, and Clinical Implications of Vaccines)
  • Systematic Review
  • Open Access
870 Views
14 Pages

20 June 2026

Background/Objectives: Re-emergence of Haemophilus influenzae serotype b (Hib) was reported in several European countries. We aimed to characterize the age distribution of H. influnezae carriage before and after Hib vaccination. Methods: We conducted...

(This article belongs to the Section Epidemiology and Vaccination)
  • Brief Report
  • Open Access
2,581 Views
10 Pages

Fasciculations Following COVID-19 Vaccination—A Case Series of Ten Patients

  • Ameli Breuer,
  • Vanessa Raeder,
  • Helena Franziska Pernice,
  • Fabian Boesl,
  • Harald Prüss,
  • Heinrich Audebert,
  • Katrin Hahn and
  • Christiana Franke

19 June 2026

Introduction: Vaccination against COVID-19 has been crucial in controlling the pandemic. While side effects are typically mild, rare neurological complications have been reported. This is a case series of ten patients who reported of persistent fasci...

(This article belongs to the Section COVID-19 Vaccines and Vaccination)
  • Article
  • Open Access
1,261 Views
15 Pages

18 June 2026

Background/Objectives: Human papillomavirus (HPV) infection is the leading cause of cervical cancer and is associated with several anogenital and oropharyngeal malignancies. Although licensed HPV vaccines are highly effective, access remains limited...

(This article belongs to the Special Issue Recent Advances and Strategies for the Management of CIN and HPV Eradication Strategies for the Prevention of Uterine Cervical Cancer)
  • Article
  • Open Access
862 Views
28 Pages

Protective Effect Against Acute Experimental Toxoplasmosis Conferred by Intranasal Immunisation with Toxoplasma gondii Membrane Proteins Plus CpG Adjuvant

  • Carina Brito,
  • Daniela Teixeira,
  • Paula Goulart,
  • Beatriz Rodrigues,
  • Nuno Carvalho,
  • Manuel Vilanova,
  • Alexandra Correia and
  • Margarida Borges

17 June 2026

Background: Toxoplasmosis is a prevalent zoonotic disease worldwide, affecting approximately one-third of the global human population. Primary infection with Toxoplasma gondii during pregnancy can induce miscarriage or congenital infection, leading t...

(This article belongs to the Special Issue Anti-Parasitic Vaccines and Host Immune Responses)
  • Article
  • Open Access
527 Views
15 Pages

17 June 2026

Background/Objectives: Childhood vaccine refusal may negatively affect immunization programs in Türkiye, where regional clusters of hesitancy have emerged despite high national coverage. This study aimed to identify sociodemographic, behavioral,...

(This article belongs to the Special Issue Acceptance and Hesitancy in Vaccine Uptake: 3rd Edition)
  • Article
  • Open Access
1 Citations
1,466 Views
16 Pages

Pakistan’s 2025 HPV Vaccine Phase I Rollout: Community Response, Implementation Challenges & Way Forward

  • Wei Xia,
  • Soofia Yunus,
  • Atta Ur Rehman,
  • Shah Nawaz Jiskani,
  • Muhammad Imran Qureshi,
  • Shawana Farooq,
  • Inam Bhatti,
  • Sunday Audu,
  • Syed Natiq Abbas Kazmi and
  • Rozina Khalid

17 June 2026

Background: The International Agency for Research on Cancer estimated around 3197 annual deaths along with 5008 newly diagnosed cases of cervical cancer in Pakistan. Worldwide, introduced in 164 WHO member states, the HPV vaccine provides over ninety...

(This article belongs to the Special Issue HPV Vaccination and Primary HPV Screening)
  • Review
  • Open Access
989 Views
19 Pages

Maternal Vaccine Acceptance and Attitudes Before and After the COVID-19 Pandemic: A Narrative Literature Review

  • Barbara Frączek,
  • Karolina Pieniawska-Śmiech,
  • Mateusz Babicki,
  • Bartosz Balcer,
  • Natalia Dolata,
  • Dagmara Pokorna-Kałwak and
  • Karolina Kłoda

17 June 2026

Objectives: This study aims to assess the acceptance of vaccinations among pregnant women, particularly against influenza, pertussis, COVID-19, and RSV, and to identify factors influencing their willingness to get vaccinated. It also seeks to evaluat...

(This article belongs to the Special Issue Maternal Vaccination and Vaccines—2nd Edition)
  • Opinion
  • Open Access
716 Views
16 Pages

16 June 2026

Obtaining market approval and reimbursement are necessary but not sufficient conditions for the implementation of new vaccines in high-income countries to maximize their long-term preventative value. Comprehensive pre-launch and launch-phase economic...

(This article belongs to the Special Issue Vaccination and Global Health Equity: Innovations, Access, and Impact)
  • Article
  • Open Access
1,138 Views
17 Pages

Development and Qualification of a Nipah Virus Glycoprotein-Specific IgG ELISA for the Assessment of Human Antibody Responses

  • Mohammad Mamun Alam,
  • Tahsin Tabassum Anonto,
  • Sinthia Karim,
  • Gathoni Kamuyu,
  • Ali Azizi,
  • Ayesha Siddika,
  • Shadman Sakib Choudhury,
  • Md Wasik Rahman,
  • Anika Farzin and
  • Mohammed Ziaur Rahman
  • + 11 authors

16 June 2026

Background/Objectives: Nipah virus (NiV) is a highly pathogenic zoonotic virus with fatality rates exceeding 70% and causes recurring outbreaks in South and Southeast Asia. Reliable serological assays are critical for outbreak surveillance, diagnosis...

(This article belongs to the Section Vaccines, Clinical Advancement, and Associated Immunology)
  • Article
  • Open Access
2 Citations
1,432 Views
19 Pages

Antibody Titres to Strangvac® Antigens Correlate with Protection and Duration of Immunity Against Experimental Infection with Streptococcus equi Subspecies equi

  • Romain Paillot,
  • Francesco Righetti,
  • Carl Robinson,
  • Lars Frykberg,
  • Margareta Flock,
  • Olof Zachrisson,
  • Bengt Guss,
  • Jan-Ingmar Flock and
  • Andrew S. Waller

16 June 2026

Background/Objectives: Strangles, caused by Streptococcus equi subspecies equi (S. equi), remains a common and severe equine infectious disease. Strangvac®, a recombinant fusion protein vaccine licenced in Europe, contains the antigens (Ag) CCE,...

(This article belongs to the Section Veterinary Vaccines)
  • Article
  • Open Access
1,275 Views
21 Pages

15 June 2026

Background/Objectives: Self-amplifying RNA (saRNA) vectors enable high-level transgene expression from minimal initial doses. While alphavirus-based saRNA systems are widely used, they suffer from limitations, including large genome size, complex rep...

  • Article
  • Open Access
990 Views
12 Pages

Longevity and Magnitude of Antibody Responses After Homologous and Heterologous COVID-19 Booster Vaccinations in Bangladesh

  • Marjahan Akhtar,
  • Md. Rashedul Islam,
  • Zahid Hasan Khan,
  • Afroza Akter,
  • Imam Tauheed,
  • Tasnuva Ahmed,
  • Ishtiakul Islam Khan,
  • Mohammad Ashraful Amin,
  • Fatema Khaton and
  • Firdausi Qadri
  • + 14 authors

15 June 2026

Background: The dynamics of humoral immune responses following primary and booster COVID-19 vaccinations are crucial to understand in order to optimize vaccination strategies. This study evaluates the magnitude and durability of SARS-CoV-2-specific I...

(This article belongs to the Special Issue COVID-19 Vaccines in the Post-Pandemic Era: Immune Responses, Boosting Strategies, and Long-Term Outcomes)
  • Article
  • Open Access
722 Views
14 Pages

15 June 2026

Introduction: Streptococcus pneumoniae severely affects adults over 65, especially those with comorbidities. Since vaccination coverage among healthcare workers (HCWs) is unknown despite free availability, this study evaluates knowledge, behaviours,...

(This article belongs to the Special Issue Acceptance and Hesitancy in Vaccine Uptake: 3rd Edition)
  • Article
  • Open Access
1 Citations
953 Views
17 Pages

Knowledge, Awareness, and Willingness Toward the HPV Vaccine Among Medical Students at Qassim University: A Cross-Sectional Study

  • Ghadah Alhetheli,
  • Rifal Alhumaid,
  • Shams Alajlan,
  • Sheyam Alajlan,
  • Lamia Alharbi,
  • Lamis Allahim and
  • Hala Ahmed Alrubah

15 June 2026

Background: Human papillomavirus (HPV) causes nearly all cervical cancers and a growing share of HPV-related malignancies in both sexes, yet HPV vaccine knowledge and acceptance among medical students in Saudi Arabia, the next generation of clinician...

(This article belongs to the Section Vaccination Against Cancer and Chronic Diseases)
  • Review
  • Open Access
999 Views
11 Pages

15 June 2026

China recently became the 155th country to provide free vaccination to all 13-year-old girls with two doses of a domestic bivalent HPV vaccine in October 2025. Such a policy change aligns with the Immunization Agenda 2030, which expects more investme...

(This article belongs to the Special Issue HPV Vaccination and Primary HPV Screening)
  • Editorial
  • Open Access
454 Views
4 Pages

14 June 2026

Influenza viruses remain a formidable challenge to global public health, causing annual epidemics and intermittent pandemics, and resulting in over 3 million severe infections with 290,000–650,000 deaths annually [...]

(This article belongs to the Special Issue Immunity to Influenza Viruses and Vaccines)
  • Article
  • Open Access
959 Views
20 Pages

Long-Lasting Antibody and CD8+ Memory T Cell Responses Induced by N-Tc52/TSKb20 Vaccination upon Trypanosoma cruzi Antigen Re-Encounter

  • María Elisa Vázquez,
  • Brenda A. Zabala,
  • Maria Constanza Barrientos,
  • Daniela E. Barraza,
  • María A. Occhionero,
  • Federico Ramos,
  • Alejandro Uncos,
  • Leonardo Acuña and
  • Cecilia Pérez Brandán

13 June 2026

Background: Chagas disease, caused by Trypanosoma cruzi, remains a major public health problem in Latin America and an emerging concern worldwide. Current chemotherapies show limited efficacy during chronic infection, and no licensed vaccine is curre...

(This article belongs to the Special Issue Innovative Vaccines and Technologies to Address Tropical Parasitic Diseases)
  • Review
  • Open Access
896 Views
42 Pages

Chimeric Pathogen-Associated Molecular Patterns (PAMPs) as Vaccine Adjuvants

  • Bethany M. Potter,
  • Anya F. Weth,
  • Emma M. Dangerfield,
  • Mattie S. M. Timmer and
  • Bridget L. Stocker

12 June 2026

The development of pathogen-associated molecular patterns (PAMPs) that signal via pathogen recognition receptors (PRRs) on innate immune cells is a strategy that is widely adopted in adjuvant research. Less well studied is how covalently linking diff...

(This article belongs to the Special Issue Novel Vaccine Designs to Enhance the Engagement of Innate and Adaptive Immunity)
  • Article
  • Open Access
6,582 Views
19 Pages

Post-Marketing Safety of mRNA Vaccines: A Real-World Study Integrating Literature Case Reports and Vaccine Adverse Event Reporting System

  • Bagejiang Tulisibaike,
  • Tian-Yi Yang,
  • Wen-Jun Gu,
  • Huan Liu,
  • Yuan-Hui Wang,
  • Jin-Qi Yang,
  • Tong Wang,
  • Si-Miao Ding,
  • Rong-Xue Cai and
  • Yu-Wen Su
  • + 4 authors

12 June 2026

Background: mRNA vaccines, first approved in December 2020, have been used globally to prevent infectious diseases, and those for treating cancers are being developed. Safety-related labelling changes of Comirnaty and Spikevax were made in June 2025;...

(This article belongs to the Special Issue mRNA Vaccines in Disease Prevention and Treatment)
  • Article
  • Open Access
586 Views
17 Pages

Larger Acute Phase Reactions Are Associated with Immunogenicity of an Adjuvanted Recombinant Receptor Binding Domain Protein Vaccine Against SARS-CoV-2 in Rhesus Monkeys

  • Christopher L. Coe,
  • Gabriele R. Lubach,
  • Francesca Nimityongskul,
  • Kimberly Luke,
  • Eva G. Rakasz,
  • David M. Rancour and
  • Fritz M. Schomburg

11 June 2026

Background: Although prolonged inflammatory symptoms are an infrequent and problematic adverse effect of vaccination that can occur in some people, the transient activation of acute phase reactants (APRs) is expected with adjuvanted vaccines and help...

(This article belongs to the Special Issue Research on Immune Response and Vaccines: 2nd Edition)
  • Article
  • Open Access
1 Citations
1,011 Views
33 Pages

Influenza Vaccine Technology Transfer: A Mixed-Methods Study with Vaccine Manufacturers and Global Experts to Assess Successes, Challenges, and Opportunities

  • Christopher Chadwick,
  • Erin Sparrow,
  • Claudia Nannei,
  • Jessica Taaffe,
  • William Ampofo,
  • Antoine Flahault and
  • Seth Berkley

11 June 2026

Background/Objectives: Technology transfer (TT) has been identified as a global health priority due to its impact on improving access to vaccines, including for pandemic influenza preparedness and response through bilateral and multilateral mechanism...

(This article belongs to the Special Issue Pandemic Influenza Vaccination)
  • Article
  • Open Access
1 Citations
1,010 Views
16 Pages

Predicting Human Papillomavirus Vaccination Uptake in Saudi Arabia: Analyzing Health Belief Model Constructs, Vaccine Hesitancy, and Pap Smear Uptake

  • Faten A. AlRadini,
  • Joud Mohammed Alibrahim,
  • Roqaya Saud Almasoud,
  • Sarah Abdullah Alsubaie,
  • Arub Magid Althbety,
  • Ghofran Hadi Alqahtani,
  • Rahil Esmail Alshanqiti,
  • Layan Mohammed Kashm,
  • Danah Abdullah Aljahdali and
  • Amel Fayed

10 June 2026

Background: Cervical cancer is among the most common cancers affecting women worldwide, with high morbidity and mortality in low- and middle-income countries. In Saudi Arabia, most cases are diagnosed at a late stage despite the availability of free...

(This article belongs to the Section Human Papillomavirus Vaccines)
  • Article
  • Open Access
464 Views
20 Pages

Characteristics of SARS-CoV-2 Reinfection and Ancestral RBD-Blocking Antibody Levels: A Cross-Sectional Study in the Post-Zero-COVID Era from Shanghai

  • Chen Chen,
  • Yuanfei Zhu,
  • Huiting Wang,
  • Fei Wu,
  • Youhua Xie,
  • Qingqing Jia,
  • Yang Yang,
  • Jiangjiang Lyu,
  • Junqiang Qu and
  • Fan Wu
  • + 1 author

10 June 2026

Background: SARS-CoV-2 reinfections increased substantially after the emergence of Omicron variants. Methods: We conducted a cross-sectional study of 2095 individuals with prior Omicron BA.2 infection in Shanghai, China, during the early post-zero-CO...

(This article belongs to the Special Issue Epidemiology, Vaccines and Surveillance of COVID-19)
  • Perspective
  • Open Access
2 Citations
1,642 Views
19 Pages

From Global Insights to Local Action: Bridging Vaccine Design and Manufacturing Gaps in H5N1 Pandemic Readiness

  • María Alicia Delfino,
  • Jimena Borgo,
  • Luciano Chaneton,
  • Natacha Cerny,
  • Augusto Ernesto Bivona,
  • Pierre Gsell,
  • Fernando Lobos,
  • Ike James,
  • Martin Friede and
  • Andrés Sánchez Alberti
  • + 1 author

10 June 2026

The global expansion of highly pathogenic avian influenza A (H5N1), particularly the clade 2.3.4.4b lineage, has renewed urgent concerns about its pandemic potential in the context of its ongoing panzootic expansion and increasing cross-species trans...

(This article belongs to the Special Issue Pandemic Influenza Vaccination)
  • Article
  • Open Access
936 Views
18 Pages

A Recombinant OMV-Based Vaccine Elicits Potent Protective Immunity Against Pseudomonas aeruginosa

  • Jiannan Li,
  • Guangyu Qi,
  • Mingyue Cao,
  • Zixian Wang,
  • Gejin Lu,
  • Xulong Lang,
  • Feng Wei,
  • Tiancheng Lu,
  • Lingwei Zhu and
  • Xiuran Wang

Background: This study aimed to construct a recombinant Pseudomonas aeruginosa outer membrane vesicle (OMV) vector vaccine delivering pcrV and compare the immunological impacts of OMVs as carriers versus as adjuvants. Methods: The recombinant plasmid...

(This article belongs to the Section Vaccines Against Tropical and Other Infectious Diseases)
  • Article
  • Open Access
851 Views
32 Pages

Complete Genomes of Human Papillomavirus Type 16 Viruses Isolated from Cases of Cervical Neoplasia and Squamous Cell Carcinomas Followed in Latvia in 2012–2024

  • Juris Jansons,
  • Nikita Zrelovs,
  • Arta Spridzane,
  • Marija Nazarenko,
  • Liba Sokolovska,
  • Karina Biserova,
  • Daira Krisane,
  • Austra Breiksa-Vaivode,
  • Daria Avdoshina and
  • Maria Isaguliants
  • + 8 authors

Background: Persistent high-risk human papillomavirus (hrHPV) infection causes over 99% of cervical precancers and cancers worldwide, with HPV genotype 16 (HPV16) responsible for 50% of the cases. Latvia ranks among the top EU countries for cervical...

(This article belongs to the Special Issue Chronic Viral Infections and Cancer: Openings for Vaccines and Cure)
  • Review
  • Open Access
2 Citations
1,218 Views
22 Pages

The magnitude and quality of adaptive immune responses are fundamentally influenced by the efficiency of antigen presentation. Traditional vaccine platforms, such as live–attenuated or inactivated pathogens, although immunogenic, often present...

(This article belongs to the Special Issue Novel Vaccine Designs to Enhance the Engagement of Innate and Adaptive Immunity)
  • Article
  • Open Access
888 Views
11 Pages

Field Testing of a Virus-Particle-Based Sow Vaccine Against F4 and STb-Positive Escherichia coli

  • Priscila R. Guerra,
  • Elisabeth O. Nielsen,
  • Ikhlaq H. Kana,
  • Søren K. Boldsen,
  • Vanesa García,
  • Ana Herero-Fresno,
  • Nicole B. Goecke,
  • Morten A. Nielsen,
  • Adam F. Sander and
  • John E. Olsen

Background/Objectives: Post-weaning diarrhea remains a major challenge in pig production worldwide. Enterotoxigenic Escherichia coli (ETEC) encoding fimbriae of the F4 type and producing the heat-stable enterotoxin, STb, are one of the important caus...

(This article belongs to the Special Issue Swine Vaccines and Vaccination)
  • Article
  • Open Access
1,018 Views
13 Pages

Towards an Original Anti-ASFV Vaccine: Cellular Immunity Induced by Extracellular Vesicles Engineered with ASFV Proteins

  • Francesco Manfredi,
  • Flavia Ferrantelli,
  • Chiara Chiozzini,
  • Micaela Donnini,
  • Patrizia Leone,
  • Katherina Pugliese,
  • Monica Cagiola,
  • Cecilia Righi,
  • Stefano Petrini and
  • Maurizio Federico
  • + 2 authors

Background/Objectives: African Swine Fever (ASF) represents one of the most serious threats to animal health and global food security. The causative agent of ASF is the African swine fever virus (ASFV), a DNA virus belonging to the Asfarviridae famil...

(This article belongs to the Special Issue Swine Vaccines and Vaccination)
  • Article
  • Open Access
1,035 Views
20 Pages

Background: Self-compassion is the practice of treating oneself with kindness and understanding during times of hardship. There is a lack of studies investigating the associations between self-compassion and vaccination behaviors. This study investig...

(This article belongs to the Section Vaccines and Public Health)
  • Article
  • Open Access
560 Views
17 Pages

Identification of Conserved Cross-Reactive B-Cell Epitopes in CPV1 and CPV2 L1 Proteins with Vaccine Potential

  • Yuge Wang,
  • Yingyi Chen,
  • Kaixin Wang,
  • Youqing Yuan,
  • Haojie Sun,
  • Youming Yuan,
  • Jixian Wang,
  • Zhicai Yang,
  • Yi Yang and
  • Aibing Wang
  • + 2 authors

Background/Objectives: Canine papillomavirus (CPV) is an important viral pathogen associated with papillomatosis in dogs, with canine papillomavirus type 1 (CPV1) and type 2 (CPV2) among the most prevalent and clinically relevant genotypes. The L1 ca...

(This article belongs to the Special Issue Animal Vaccines: 2nd Edition)
  • Brief Report
  • Open Access
870 Views
6 Pages

MMR Vaccination and Hen’s Egg Allergy: Bridging the Gap Between Evidence and Clinical Practice

  • Weronika Marta Balas,
  • Maja Kaczor,
  • Joanna Strzelecka and
  • Adam Jerzy Sybilski

Background: Measles has re-emerged in recent years as a public health concern in the context of insufficient vaccination coverage. Some children experience significant delays in receiving, or refuse to take, the measles, mumps and rubella (MMR) vacci...

(This article belongs to the Section Vaccine Advancement, Efficacy and Safety)
  • Article
  • Open Access
1 Citations
957 Views
19 Pages

Development and Preliminary Mechanistic Evaluation of a Novel Liposomal QS-21 and CpG ODNs Adjuvant System for Enhancing Vaccine Immunogenicity

  • Jun Ge,
  • Kangwei Xu,
  • Yong Cao,
  • Jiaojiao Sun,
  • Lili Guo,
  • Lilong Sun,
  • Ke Liu,
  • Jinbiao Lu,
  • Jianqiang Li and
  • Yixuan Zhang

Developing potent adjuvants is critical for enhancing vaccine efficacy, particularly for subunit antigens. Background/Objectives: This study evaluates a novel composite adjuvant system combining liposomal QS-21 and CpG ODNs to enhance vaccine-induced...

(This article belongs to the Section Vaccine Design, Development, and Delivery)
  • Review
  • Open Access
1,593 Views
35 Pages

Therapeutic Vaccines for Chronic Viral Infections: From Immune Modulation to Clinical Translation

  • Zhuang Li,
  • Yuan Zhang,
  • Yiyang Zheng,
  • Hongyu Wang,
  • Chenyang Xu and
  • Qing He

Therapeutic vaccines are a key strategy to achieve the goal of “functional cure” of chronic viral infections, including hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), human papillomavirus (HPV), and...

(This article belongs to the Special Issue Vaccine Design and Development)
  • Article
  • Open Access
1,239 Views
17 Pages

Critical Path to First-in-Human Batches of ChAdOx Vectors, Including for Emergency Response

  • Marco Polo Peralta Alvarez,
  • Shawkat Hussain,
  • Andrea Magri,
  • Jacqueline Vieira,
  • Cheelsea Pereira,
  • Faith Vinluan,
  • Matteo N. Barbaglia,
  • Daniel Wright,
  • Susan J. Morris and
  • Alexander D. Douglas
  • + 7 authors

Background: Adenovirus-vectored vaccines played an important role in the global response to SARS-CoV-2. Adenovirus platforms have many advantages including a simple and readily transferred manufacturing process, low cost, and thermostability. Speed o...

(This article belongs to the Special Issue Viral Vector-Based Vaccines)
  • Review
  • Open Access
1 Citations
1,274 Views
27 Pages

Viral Vaccine Adjuvant Strategies for Shaping Durable Immunity Across the Human Lifespan

  • Swarandeep Singh,
  • Surabhi Gautam,
  • Vidhi Thakkar,
  • Sanjeev Kumar and
  • Devyani Joshi

Vaccination remains one of the most effective strategies for preventing infectious diseases. Yet, the success of modern vaccines increasingly depends on the rational design of adjuvants that enhance and shape immune responses. In this review, we exam...

(This article belongs to the Special Issue Advances in Vaccine Adjuvants)
  • Article
  • Open Access
623 Views
21 Pages

Background: Pseudorabies vaccines based on the live attenuated PRV Bartha-K61 strain remain essential for controlling pseudorabies in swine, but poor thermal stability during storage and transport limits field use. Objectives: This study aimed to dev...

(This article belongs to the Special Issue Animal Immunity and Veterinary Vaccine)
  • Systematic Review
  • Open Access
1 Citations
1,388 Views
23 Pages

A Systematic Review and Meta-Analysis on the Effectiveness of Interventions in Reducing Missed Opportunities for Vaccination Among Children Under Age Five

  • Jacques L. Tamuzi,
  • Patrick D. M. C. Katoto,
  • Doris Y. Sakala,
  • Serge M. Zigabe,
  • Charles S. Wiysonge and
  • Peter S. Nyasulu

Introduction: A knowledge gap exists around which interventions can be implemented to minimise missed opportunities for vaccination (MOVs) in children under age five. Children under age five experience higher rates of MOVs, making them a critical foc...

(This article belongs to the Special Issue Vaccine Epidemiology and Population Health)
  • Article
  • Open Access
1 Citations
986 Views
13 Pages

Mpox-Related Knowledge, Risk Perception, and Vaccination Willingness Among University Students in Aktobe, Kazakhstan: A Cross-Sectional Study

  • Dilnaz Konbayeva,
  • Lespek Kutumbetov,
  • Balzhan Myrzakhmetova,
  • Olga Chervyakova,
  • Kuandyk Zhugunissov,
  • Askhat Myngbay,
  • Gulnar Altayeva,
  • Saida Askatkyzy,
  • Togzhan Nurdauletova and
  • Arman Issimov
  • + 2 authors

Background: Mpox is a re-emerging viral zoonotic disease that remains relevant for public health preparedness, risk communication, and vaccination literacy. University students are an important population for infectious disease communication because...

(This article belongs to the Section Vaccines and Public Health)
  • Article
  • Open Access
1,445 Views
20 Pages

HPV Vaccination Uptake and Acceptability of HPV/HIV Integrated Services Models for Adolescent Girls in Mozambique and Zimbabwe: The AIM-HPV Implementation Research Study

  • Michelle M. Gill,
  • Assucênio Chissaque,
  • Edna Viegas,
  • Lillian Chinyanganya,
  • Hilda Bara,
  • Lauren Greenberg,
  • Nontokozo Gava,
  • Mahira Amade,
  • Bridget Kanengoni and
  • Rhoderick Machekano
  • + 8 authors

Background/Objectives: Girls living with HIV (GLHIV) or vulnerable to HIV have a higher risk of HPV infection and cervical cancer as they age. We determined acceptability and vaccination uptake after integrating HPV vaccination into HIV prevention an...

(This article belongs to the Special Issue Strategies to Increase the Uptake and Delivery of HPV Vaccination in LMICs)
  • Review
  • Open Access
1 Citations
1,650 Views
21 Pages

Vaccination Against Serogroup B Meningococcal Disease: Current Status and Future Perspectives—A Consensus Document of the World Association for Infectious Diseases and Immunological Disorders (WAidid)

  • Susanna Esposito,
  • Nigel Curtis,
  • Ulrich Heininger,
  • Markus Knuf,
  • Shamez Ladhani,
  • Helen Marshall,
  • Federico Martinon-Torres,
  • Marco Safadi,
  • Vana Spoulou and
  • Nicola Principi
  • + 1 author

Background: Invasive meningococcal disease (IMD) remains a rare but severe condition associated with high mortality and a significant risk of long-term sequelae. Despite global vaccination efforts, the epidemiology of Neisseria meningitidis continues...

(This article belongs to the Special Issue Pediatric Infectious Diseases and Immunization)

of 2

XFacebookLinkedIn
Vaccines - ISSN 2076-393X